Development of Erlotinib-Loaded Nanotransferosomal Gel for the Topical Treatment of Ductal Carcinoma in Situ

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Design, statistical optimization, and characterization of Esculin-loaded transliposome nanogel for topical delivery: In-vitro, ex vivo study and dermatokinetic evaluation2024 · 4 citations
2. 2Ultra-Stabilized Transethosomal Gel for Co-Delivery of 5-Fluorouracil and Carvedilol: Cytotoxicity and In-vivo studies in Skin Cancer2026
3. 3Optimized Beta-Sitosterol Transethosomal Gel OutperformsTransferosomes for Enhanced Transdermal Delivery and Cytotoxicity inBreast Cancer Therapy2026
4. 4Novel embelin‐loaded transniosomes for topical delivery: comprehensive exploration of <scp><i>in vitro</i></scp>, <scp><i>ex vivo</i></scp> and dermatokinetic assessment for anti‐cancer activity2024 · 3 citations
5. 5Quality by Design-Endorsed Nilotinib-Laden Liposomal Gel for Enhanced Dermal Delivery in Melanoma Management: Fabrication, Optimization, <i>In Silico, In Vitro</i> , and <i>Ex Vivo</i> Studies2026